Immunologic alterations induced by phenytoin
Levo, Y.
New England Journal of Medicine 307(5): 315-316
1982
ISSN/ISBN: 0028-4793 PMID: 6211620 Document Number: 192464
Document emailed within 1 workday
Related Documents
Hernández, R.; Fernández, M.d.l.A.; Miranda, G.; Suástegui, R. 2005: Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 57(4): 522-531Schumer, W. 1988: Metabolic and immunologic alterations of sepsis in the elderly Progress in Clinical and Biological Research 264: 223-231
Kjer, J.J. 1978: Phenytoin-induced agranulocytosis Ugeskrift for Laeger 140(25): 1493
Frentz, G. 1977: Phenytoin-induced acne Ugeskrift for Laeger 139(6): 338-339
Prakash, J.S.S.; Srivastava, A.; Strasser, R.J.; Mohanty, P. 2003: Senescence-induced alterations in the photosystem Ii functions of Cucumis sativus cotyledons: probing of senescence driven alterations of photosystem Ii by chlorophyll a fluorescence induction O-J-I-P transients Indian Journal of Biochemistry and Biophysics 40(3): 160-168
Gaffey, C.M.; Chun, B.; Harvey, J.C.; Manz, H.J. 1986: Phenytoin-induced systemic granulomatous vasculitis Archives of Pathology and Laboratory Medicine 110(2): 131-135
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Weihrauch, T.R.; Köhler, H.; Höffler, D.; Rieger, H.; Krieglstein, J. 1975: Effect of diazepam and phenytoin on penicillin-induced convulsions Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1653-1656
Meng, H.X. 1988: Ultrastructural study on phenytoin-induced gingival proliferation Zhonghua Yi Xue Za Zhi 68(1): 31
Blanco, A.; Palencia, R.; Solis, P.; Arranz, E.; Sánchez Villares, E. 1986: Transient phenytoin induced IgA deficiency and permanent IgE increase Allergologia et Immunopathologia 14(6): 535-538
Talesnik, E.; Rivero, S.J.; González, B. 1989: Serum IgA deficiency induced by prolonged phenytoin treatment Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 41(4): 331-335
Dahllöf, G.; Axiö, E.; Modéer, T. 1991: Regression of phenytoin-induced gingival overgrowth after withdrawal of medication Swedish Dental Journal 15(3): 139-143
Sandyk, R. 1981: Choreo-athetosis induced by phenytoin in an epileptic child. A case report South African Medical Journal 60(16): 627-628
Lance, S.; Ternouth, I. 2015: Fluoxetine-induced phenytoin toxicity: a clinical reminder about the perils of polypharmacy New Zealand Medical Journal 128(1422): 78-79
Balakrishnan, S.; Pandhi, P. 1997: Effect of nimodipine on the cognitive dysfunction induced by phenytoin and valproate in rats Methods and Findings in Experimental and Clinical Pharmacology 19(10): 693-697
Pandhi, P.; Balakrishnan, S. 1999: Cognitive dysfunction induced by phenytoin and valproate in rats: effect of nitric oxide Indian Journal of Physiology and Pharmacology 43(3): 378-382
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Baenkler, H.W. 1977: Immunologic disorders. 9. Immunologic defects and immunologic insufficiency, malignant immunoproliferation Fortschritte der Medizin 95(2): 71-75
Lin, S.Y.; Wu, C.T.; Yeh, C.C.; Liu, S.T.; Ho, S.T.; Wong, C.S. 1999: Ephedrine-induced complete atrioventricular block with ventricular asystole during rapid concomitant phenytoin infusion: a case report Acta Anaesthesiologica Sinica 37(1): 45-48